Company No: 16398644 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	31.03.2026
		£
Fixed assets
Investments	3	733,427
		733,427
Current assets
Debtors	4	714,590
Cash at bank and in hand		256
		714,846
Creditors: amounts falling due within one year	5	( 740,176)
Net current liabilities		(25,330)
Total assets less current liabilities		708,097
Creditors: amounts falling due after more than one year	6	( 785,521)
Net liabilities		( 77,424)
Capital and reserves
Called-up share capital	7	141
Share premium account		64,859
Profit and loss account		( 142,424 )
Total shareholders' deficit		( 77,424)

For the financial period ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Leviathan Newco 4 Limited (registered number: 16398644) were approved and authorised for issue by the Board of Directors on 15 September 2026. They were signed on its behalf by:

D S Sneddon Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Leviathan Newco 4 Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Flat 28 Speed House, Barbican, London, EC2Y 8AT, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors note that the business has net liabilities of £77,424. The Company is supported through loans from the directors. The directors have confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the directors will continue to support the Company. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption in section 399 of the Companies Act 2006 not to prepare consolidated accounts, because the group it heads qualifies as small. The financial statements present information about the Company as an individual entity only.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Shareholder loans

Shareholder loans are recognised initially at the transaction price, being the proceeds received net of directly attributable transaction costs. Interest payable on shareholder loans is recognised within finance costs in the profit and loss account on an accruals basis so as to produce a constant periodic rate of interest on the outstanding liability. Shareholder loans are classified as creditors due within one year where repayment is due within twelve months of the reporting date. Loans for which repayment is not due within twelve months after the reporting date are classified as creditors due after more than one year. Any accrued but unpaid interest is included within creditors and recognised as part of the carrying value of the loan

2. Employees

	Period from 22.04.2025 to 31.03.2026
	Number
Monthly average number of persons employed by the Company during the period, including directors	0

3. Fixed asset investments

Investments in subsidiaries

	31.03.2026
	£
Cost
At 22 April 2025	0
Additions	733,427
At 31 March 2026	733,427
Carrying value at 31 March 2026	733,427

4. Debtors

	31.03.2026
	£
Amounts owed by own subsidiaries	694,422
VAT recoverable	6,968
Other debtors	13,200
	714,590

5. Creditors: amounts falling due within one year

	31.03.2026
	£
Amounts owed to own subsidiaries	206,400
Other loans (secured)	294,218
Accruals	19,016
Other creditors	220,542
	740,176

The above borrowings from SME Lending Limited are secured by a debenture dated 13 June 2025 comprising fixed and floating charges over substantially all of the Company's assets and undertaking

Included within other creditors is deferred consideration of £99,410 arising from a Share Purchase Agreement dated 13 June 2025. The deferred consideration is secured by a fixed and floating charge over the Company's assets and undertaking in favour of Leviathan Newco 3 Limited (in Administration)

6. Creditors: amounts falling due after more than one year

	31.03.2026
	£
Other loans (secured)	700,521
Other creditors	85,000
	785,521

The above borrowings from SME Lending Limited are secured by a debenture dated 13 June 2025 comprising fixed and floating charges over substantially all of the Company's assets and undertaking

7. Called-up share capital

	31.03.2026
	£
Allotted, called-up and fully-paid
1,406 Ordinary shares of £ 0.10 each	141

On incorporation, 1 ordinary share of £1 each was issued at par.
On 29 May 2025, 1 share of £1 was sub divided into 1,000 shares of £0.1 each.
On 30 May 2025, a further 406 ordinary shares of £0.1 each were issued at a premium of £159.9 per share.

8. Related party transactions

Transactions with entities in which the entity itself has a participating interest

The company has taken advantage of the exemptions within FRS 102 paragraph 33.1A from disclosing transactions with its wholly owned subsidiaries

9. Off Balance Sheet arrangements

On 30 May 2025, the company entered into an unsecured shareholder loan agreement with shareholders for £85,000. As additional consideration for the loan, the company granted 532 warrants over ordinary shares exercisable at £160 per share. The warrants vested immediately on grant and are exercisable for five years from the date of issue. The directors have assessed the fair value of the warrants at grant date and concluded that the amount is not material to the financial statements. Accordingly, no material adjustment has been recognised in respect of the warrants. The warrants remain outstanding at the balance sheet date